医药化工产品质量管理中存在的问题及干预对策  

Problems and Countermeasures in Quality Anagement of Pharmaceutical andChemical Products

作　　者：王丽丽 WANG Li-li(Shandong Prohanxing Pharmaceutical Co.,Ltd.,Changyi 261312,China)

机构地区：[1]山东普洛汉兴医药有限公司,山东昌邑261312

出　　处：《化工管理》2021年第11期69-70,共2页Chemical Engineering Management

摘　　要：随着中国经济水平的不断增长,人口老龄化趋势以及生存环境恶化的影响下,医药企业在医药市场中承担起提供足够医药资源的重任,并且逐渐成为促进社会经济发展的主力军。药品的质量与社会的安定以及人们的健康息息相关,但是就目前现状而言,因医药化工产品质量不过关而引发的恶性事件层出不穷,对人们的生命健康造成严重威胁,催促着医学界及其他相关业内人士必须要不断加强对医药化工产品质量管理的干预与研究。With the development of China’s economy,the trend of population ageing and the deterioration of the living environment,the pharmaceutical enterprises have taken on the task of providing sufficient medical resources in the pharmaceutical market,and gradually become the main force to promote social and economic development.The quality of medicines is closely related to social stability and people's health.However,as far as the current situation is concerned,there are numerous malignant incidents caused by the poor quality of pharmaceutical and chemical products,posing a serious threat to people's life and health,it urges the medical profession and other relevant personage to strengthen the intervention and research on the quality control of pharmaceutical and chemical products.

关 键 词：医药化工产品 质量管理 存在问题 干预对策 

分 类 号：TQ46[化学工程—制药化工]